MONTPELLIER, France, April 26, 2012 /PRNewswire/ --
Online news publication in-PharmaTechnologist.com today launched a refocused website to deliver more targeted news in key biopharma manufacturing niches.
Using the new, clearer design readers can customise in-PharmaTechnologist.com to show one of four microsites - Ingredients, Processing, Drug Delivery, and Regulatory & Safety - each of which delivers highly targeted news.
Independent, free and authoritative biopharma manufacturing news is still the focus, but the 70,000 monthly visitors to in-PharmaTechnologist.com will now find it easier to get their daily dose. Improving the reader experience of each of these is at the heart of the refocusing.
"In refocusing the site we listened to our readers and focused our efforts on the topics that matter most to their businesses," Jean-Marc Cocogne, executive director at in-PharmaTechnologist.com, said. "From the microsites to the new look, our goal is to break news from an international perspective and focus on the information that impacts the global pharmaceutical industry."
As part of a commitment to reporting biopharma manufacturing daily news, wherever it takes place, in-PharmaTechnologist.com is strengthening its presence in North America and Asia-Pacific, where more than two-thirds of its audience logon from.
To serve these readers the in-PharmaTechnologist.com team of independent journalists will spend more-and-more time on the ground in both regions, meeting the people that matter, reporting the news others miss.
New Formula, Better Effect! Check it out http://www.in-PharmaTechnologist.com.
in-PharmaTechnologist.com is an online news service available as a free-access website that provides daily and weekly newsletters to subscribers. The service seeks out news stories and data of value to decision-makers in the pharmaceutical manufacturing sector.
The in-PharmaTechnologist.com team is led by award-winning journalists who scan scientific, technical and industry sources to find previously unpublished material, primary data and expert opinions in all areas of significance to the target audience.
Copyright©2010 PR Newswire.
All rights reserved